<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:department>Research and Enterprise Services</gtr:department><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/62F517BD-0F2D-4D04-973D-F7CDEA8DFC5C"><gtr:id>62F517BD-0F2D-4D04-973D-F7CDEA8DFC5C</gtr:id><gtr:firstName>Tim</gtr:firstName><gtr:surname>Cawston</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/05587859-27D4-4020-AF1E-FC5EF64CF07D"><gtr:id>05587859-27D4-4020-AF1E-FC5EF64CF07D</gtr:id><gtr:firstName>Christopher</gtr:firstName><gtr:surname>Day</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0801671"><gtr:id>0B2BC1F8-CBB3-4490-951C-97F092FA309D</gtr:id><gtr:title>DPFS Resource request (Newcastle University)</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0801671</gtr:grantReference><gtr:abstractText>To get a new drug on the market that will prevent or cure disease is slow, costly and difficult. It involves a large team of people who, although experts, find it difficult to understand anything outside of their own subject. To speed up this process we need to get them talking (and listening) to each other. This will mean that the new drugs reach the patients much sooner.

The MRC have introduced a new funding scheme to appoint people who can bring everyone involved together, help them to share their special knowledge and identify the next critical steps to deliver new treatments to patients.</gtr:abstractText><gtr:technicalSummary>The aim of Newcastle University?s Faculty of Medical Sciences is to be the foremost site for translational medicine in the UK; we attach great importance to identifying and translating new discoveries and establishing new treatments into routine clinical practice across the UK. A recent review of research council funding and translational research activity examined the barriers that existed for the delivery of the agenda identified by the Cooksey Review. In the light of the findings the Faculty has undertaken a complete review of structures, established a joint research office and strategy committee with the local NHS Trusts, a new Translational Medicine Board and restructured the entire Faculty around its research strategy establishing eight research Institutes all of which co-locate scientists and clinicians.
However there is still a gap between fundamental discoveries at the laboratory bench made by scientists and their development toward a therapeutic benefit to humans driven by clinicians. Although there is a general desire to exploit advances in basic biomedical research to improve health in practice this is often difficult to achieve and the reasons for this are complex.
This application requests funding to appoint and support a DPFS research translator, for a period of two years, who will work closely with the Dean of Research and identify opportunities and assist PIs in the development of projects. The Newcastle MRC DPFS post would be housed within the Faculty of Medical Sciences but be line managed and be part of the Business Development Directorate and would be incorporated within the Faculty funding stream at the end of the 2 year period.</gtr:technicalSummary><gtr:fund><gtr:end>2011-08-22</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-03-23</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>127109</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Presentation to Research Office</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>9CC1B084-3C49-41FC-9019-FE395503BB24</gtr:id><gtr:impact>Presentation on Translational funding schemes, cost requirements, milestone breakdown and ongoing monitoring against budget

Staff in the research office understand the system for milestone costing Completed raining on PFACT (costing system) Process for financial management agianst milestones implemented with Research accounting department</gtr:impact><gtr:outcomeId>D848A0B8015</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation to Business Development/Technology Transfer</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>8D285107-5004-4622-9569-689A1D6078DF</gtr:id><gtr:impact>Presentation on Translational Funding schemes, those available, the remit and requirements with respect to BD/TTO input and ongoing management. Discussed means to identify projects with potential for Translational Funding

Access to and attend 2 weekly commercial opportunities meeting in Business Development. Access to data base of BD/TTO commercial opportunities and projects with IP Screen of R&amp;amp;D projects data base to identify project for Translational funding. Strategy to search commercial and R&amp;amp;D databases to identify potential projects for translational research and proactively approach the PI.</gtr:impact><gtr:outcomeId>E77C0508289</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Information day on MRC Experimental Medicine for mental health</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>208B86ED-E1F2-41BE-B56A-EBF0DEF8B404</gtr:id><gtr:impact>2 way discussion of the requirements/aims of this new funding scheme with the PM Jayne Bailey.

MRC recieved feedback on this call for input into scope &amp;amp; remit.</gtr:impact><gtr:outcomeId>igiFKNchpwt</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Improving Grant Success</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>D9543812-6573-4AFE-B185-AEE95DC1C537</gtr:id><gtr:impact>View of how reviewers judge applications provided to applicants

Some indication of improvement in grant success rates with the MRC</gtr:impact><gtr:outcomeId>oY3juBWCgzo</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Opportunities meetings with Business Development Directorate</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>AE007A6E-3D71-4BF4-B156-597310A5B150</gtr:id><gtr:impact>Co-ordination with Business Development Directorate for review of potential commercial projects.
Searching of BDD data bases to identify potential translational projects
Decisions on route for progression via translational funding, IPR grant applications, partnerships etc.

2 HICF applications in round 3 both invited to full applications in Jan 11.
2 DPFS applications identified, 1 submitted to ful Nov 10.</gtr:impact><gtr:outcomeId>Fk9hNVx5Bwr</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Building Research Relationships with Industry</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>3DD76C5E-AF29-4203-87EC-473A7879C011</gtr:id><gtr:impact>Development of contacts with Industry with the aim of collaborative projects/grant applications with Industrial Partners

Visit to Medical device developer and Manufacturer with knowledge and expertise in regulatory approval of medical devices. Review of product development plans
Reinforced relationship with large pharma Company via their new product development manager.
Discussions ongoing with 4 Newcastle academics on potential collaborative projects</gtr:impact><gtr:outcomeId>ovL6Gx9tEtP</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>683810</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Developmental Pathway Funding Scheme (DPFS)</gtr:description><gtr:end>2012-02-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>A598A9BB-E267-496D-A6C8-D51C2888C5B2</gtr:id><gtr:outcomeId>B53A768E9F80</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>673681</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Developmental Pathway Funding Scheme (DPFS)</gtr:description><gtr:end>2019-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/N018915/1</gtr:fundingRef><gtr:id>4B3857F2-CB93-4FB7-BF28-C653A38720EB</gtr:id><gtr:outcomeId>58be82f5372862.93400403</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1104576</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Health Innovation Challenge Fund (Wellcome Trust &amp;amp; Department of Health)</gtr:description><gtr:end>2014-04-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>4ABB6139-B5F0-4F27-B3BC-F384A7B0602A</gtr:id><gtr:outcomeId>jgJLfCBTZ990</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>288570</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Experimental Medicine for Mental Health</gtr:description><gtr:end>2014-02-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/J011835/1</gtr:fundingRef><gtr:id>FA498125-1E9C-4DD3-815F-B8ECA8EFEAA3</gtr:id><gtr:outcomeId>DeXQVH83yAa</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>747000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC DPFS</gtr:description><gtr:end>2013-11-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>4C54DF8B-5CC4-4F52-96D0-B42BAED578D2</gtr:id><gtr:outcomeId>YEJGc99Bwwu0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Knowledge Transfer Award</gtr:description><gtr:end>2013-01-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:id>E01C1C95-7D50-439E-9A25-D268A1BD1FB3</gtr:id><gtr:outcomeId>Wn2HKsMB9sF0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>10883200</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Innovative Engineering for Health</gtr:description><gtr:end>2021-04-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>3A56A507-4F36-4526-A665-D0DEA7D47C0C</gtr:id><gtr:outcomeId>XwQ26Q3kof9</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>473850</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Developmental Pathway Funding Scheme (DPFS)</gtr:description><gtr:end>2020-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>mr/n00607/1</gtr:fundingRef><gtr:id>F42A679E-B19F-47AA-9868-DD8B8B78AB42</gtr:id><gtr:outcomeId>58be83db34d4c9.34745003</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1029567</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Biomedical Catalyst: Developmental Pathway Funding Scheme (DPFS)</gtr:description><gtr:end>2017-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>1339ED8D-44D3-4A57-B980-C55E409E9B72</gtr:id><gtr:outcomeId>r1mthVVuynw</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>324000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Developmental Clinical Studies</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>921ADE7E-0A85-4528-B1F8-8A25F0F2B985</gtr:id><gtr:outcomeId>dMrRHaqLVHu0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Health Innovation Challenge Fund</gtr:description><gtr:end>2014-12-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>2E18935E-1F8C-4401-8494-55CEB8B25599</gtr:id><gtr:outcomeId>iVBnGroyALi0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>515715</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Health Innovation Challenge Fund (HICF)</gtr:description><gtr:end>2016-06-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>100935/Z/13/Z HICF-R7-395</gtr:fundingRef><gtr:id>E7C6C378-0204-4DC6-AD12-B8507A258CE6</gtr:id><gtr:outcomeId>THbtDgYFsiA</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>377849</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>i4i Challenge Award</gtr:description><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>24F136E0-F9C9-4E1F-8CB4-4F65E5BED64C</gtr:id><gtr:outcomeId>bEbMxB1QZiu</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Integrate Project Management Skills into Research Institute Administration</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>33621B93-C3EE-419D-94DB-8F24F492C8C6</gtr:id><gtr:impact>Key transferrable skill for career path of PI's</gtr:impact><gtr:outcomeId>1BAC4C53219</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Set up pre application project review process</gtr:description><gtr:geographicReach>Local/Municipal/Regional - UK Only</gtr:geographicReach><gtr:id>6B662160-FBDF-432B-A074-657E0EBEBACD</gtr:id><gtr:impact>All potential translational projects are reviewed against key criteria of patient and commercial benefit with technical and commercial experts. This means that risks, issues are raised and addressed pre application. A project sponsor (senior level) is nominated to support the application who can alocate resources as required.</gtr:impact><gtr:outcomeId>esFcHLFZ6ZC</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of Faculty Translational Medicine Committee (FTMC)</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>650BF6B1-F6CF-439A-9504-F9E14C27D72C</gtr:id><gtr:impact>This committee directs policy for Translational Medicine and aligns with the NIHR funding schemes designed to fund projects relevant to Health policy</gtr:impact><gtr:outcomeId>46D4BE60122</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>PI's understand Translational pipeline for Drug and Diagnostic Development</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>E282E98D-728D-42B4-BD3D-99E1CDA923C2</gtr:id><gtr:impact>Supports strategy to increase anagement and success in Translational Reasearch at Newcastle</gtr:impact><gtr:outcomeId>BF0F9D6D590</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>PI's gain experience in Project Management</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>2343A778-8C2F-468B-9D79-F87307D61234</gtr:id><gtr:impact>Key transferrable skill for career path of PI's</gtr:impact><gtr:outcomeId>6C1A22EBDA9</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Increased interest from Medical Institutes re Translational Funding Schemes</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>E733F2FB-5591-4435-97BF-4B6BC7E355EF</gtr:id><gtr:impact>NA</gtr:impact><gtr:outcomeId>3739C1F1C20</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Extend expertise in other early translational schemes</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>0901B08B-2AFB-4E0E-B4AC-DE1FB3638524</gtr:id><gtr:impact>Post holder attended 4 days training on the requirements for i4i applications/projects.</gtr:impact><gtr:outcomeId>L9NBiKS2qBJ</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Set up and co-ordination of multidisciplinary teams to deliver success in Translational funding</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>457AFC19-5882-4696-910A-39B3A4DC91AE</gtr:id><gtr:impact>Teams of Academic, Business Development/Technology Transfer, Finance, Institute administration brought together and co-ordinated to deliver success in translational funding</gtr:impact><gtr:outcomeId>33179A6B31B</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Develop Industrial Collaborations</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>F869DC0A-0D2D-49AE-940C-4DD1505F4039</gtr:id><gtr:impact>Planned Aims
To improve success rates for grant funding
To lead to Industrially funded collaborative projects
2 HICF applications and 1 DPFS application with Inductry partners</gtr:impact><gtr:outcomeId>TfsPyydjYfC</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Project Management Process</gtr:description><gtr:id>35E17914-1949-4F45-A1DA-A1D513A9ED08</gtr:id><gtr:impact>Provides the basis for management and control of translational projects. Sets out roles &amp;amp; responsibilities, systems for communications, reporting, Risk assessment and change control systems and business assessment</gtr:impact><gtr:outcomeId>787AFA9F62B</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Prince 2 Project Management</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Project planning tool</gtr:description><gtr:id>491BDB09-674F-4A01-9FF5-809D1FDC11A1</gtr:id><gtr:impact>Used to plan and justify milestones/timelines/resources required for applications to translational research funding schemes.</gtr:impact><gtr:outcomeId>4EA656DBCB9</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>MS project</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>2 staff members attended introductory training in Prince 2 project management</gtr:description><gtr:id>882D21A2-E03D-4BD0-BAD8-E404FBC6EC68</gtr:id><gtr:impact>Development of skills in staff supporting translational projects in Research Support and Business development functions</gtr:impact><gtr:outcomeId>GqPTrGrHANr</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Prince 2 project management</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Flow chart</gtr:description><gtr:id>547317BD-E73D-4F11-BB6E-468FDB82706A</gtr:id><gtr:impact>Aim to improve quality of application and thereby improve success rates</gtr:impact><gtr:outcomeId>pU6Y2fTGdAd</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Standard Operating Procedure for Translational applications</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">G0801671</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>5191BE6E-A234-4D62-A4F3-B50DBAAE8217</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>4.5  Resources and infrastructure (detection)</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>A056411B-DD7A-4062-BE33-7849FBC9BFA7</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>5.9  Resources and infrastructure (development of treatments)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>